Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers

Given the success of targeted agents in specific populations it is expected that some degree of molecular biomarker testing will become standard of care for many, if not all, cancers. To facilitate this, cancer centers worldwide are experimenting with targeted “panel” sequencing of selected mutation...

Descripción completa

Detalles Bibliográficos
Autores principales: Laskin, Janessa, Jones, Steven, Aparicio, Samuel, Chia, Stephen, Ch'ng, Carolyn, Deyell, Rebecca, Eirew, Peter, Fok, Alexandra, Gelmon, Karen, Ho, Cheryl, Huntsman, David, Jones, Martin, Kasaian, Katayoon, Karsan, Aly, Leelakumari, Sreeja, Li, Yvonne, Lim, Howard, Ma, Yussanne, Mar, Colin, Martin, Monty, Moore, Richard, Mungall, Andrew, Mungall, Karen, Pleasance, Erin, Rassekh, S. Rod, Renouf, Daniel, Shen, Yaoqing, Schein, Jacqueline, Schrader, Kasmintan, Sun, Sophie, Tinker, Anna, Zhao, Eric, Yip, Stephen, Marra, Marco A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2015
Materias:
Precision Medicine in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850882/
https://www.ncbi.nlm.nih.gov/pubmed/27148575
http://dx.doi.org/10.1101/mcs.a000570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850882/
https://www.ncbi.nlm.nih.gov/pubmed/27148575
http://dx.doi.org/10.1101/mcs.a000570

Ejemplares similares